TEVA:NYE-Teva Pharma Industries Ltd ADR (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 22.42

Change

+0.21 (+0.95)%

Market Cap

N/A

Volume

3.03M

Analyst Target

USD 12.19
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

+0.42 (+0.26%)

USD 74.37B
HLN Haleon plc

+0.02 (+0.21%)

USD 44.13B
TAK Takeda Pharmaceutical Co Ltd A..

N/A

USD 42.24B
RDY Dr. Reddy’s Laboratories Ltd..

+0.18 (+1.16%)

USD 13.11B
CTLT Catalent Inc

N/A

USD 11.52B
ELAN Elanco Animal Health

+0.02 (+0.17%)

USD 5.75B
AMRX Amneal Pharmaceuticals, Inc. C..

+0.06 (+0.77%)

USD 3.59B
BHC Bausch Health Companies Inc

+0.05 (+0.67%)

USD 2.75B
CPHI China Pharma Holdings Inc

+0.01 (+5.00%)

USD 3.69M
YCBD cbdMD Inc

+0.01 (+2.28%)

USD 1.96M

ETFs Containing TEVA

ISRA VanEck Israel ETF 10.29 % 0.60 %

+0.44 (+0%)

USD 0.09B
FLWR:SW 5.80 % 0.00 %

N/A

N/A
ISRPF iShares Public Limited Co.. 5.39 % 0.00 %

N/A

USD 2.22B
GVIP Goldman Sachs Hedge Indus.. 2.56 % 0.45 %

+1.10 (+0%)

USD 0.32B
ALFI 0.00 % 0.88 %

N/A

N/A
EIS iShares MSCI Israel ETF 0.00 % 0.59 %

+0.79 (+0%)

N/A
GNRX 0.00 % 0.55 %

N/A

N/A
GWL 0.00 % 0.34 %

N/A

N/A
ISRL:LSE 0.00 % 0.00 %

N/A

N/A
TASE:LSE 0.00 % 0.00 %

N/A

N/A
IS3T:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
ISRCF iShares V Public Limited .. 0.00 % 0.00 %

+0.32 (+0%)

N/A
ISRHF iShares V Public Limited .. 0.00 % 0.00 %

+0.10 (+0%)

N/A
ISRUF iShares V Public Limited .. 0.00 % 0.00 %

+0.02 (+0%)

N/A
ISRZF iShares II Public Limited.. 0.00 % 0.00 %

N/A

N/A
ISRIF 0.00 % 0.00 %

N/A

N/A
ISRVF iShares Public Limited Co.. 0.00 % 0.00 %

N/A

N/A
ISRWF 0.00 % 0.00 %

N/A

N/A
ISRNF 0.00 % 0.00 %

N/A

N/A
ISRRF 0.00 % 0.00 %

N/A

N/A
FLWG:LSE 0.00 % 0.00 %

N/A

N/A
FLWR:LSE 0.00 % 0.00 %

N/A

N/A
BLUM:XETRA 0.00 % 0.00 %

N/A

N/A
BLUM:F 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 114.75% 93% A 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 114.75% 93% A 98% N/A
Trailing 12 Months  
Capital Gain 113.93% 93% A 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 113.93% 93% A 98% N/A
Trailing 5 Years  
Capital Gain 121.10% 100% F 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 121.10% 100% F 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 10.52% 73% C 66% D+
Dividend Return 10.52% 60% D- 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 40.72% 53% F 24% F
Risk Adjusted Return 25.84% 60% D- 40% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector